Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications

https://www.tenayatherapeutics.com/tenaya-therapeutics-unveils-preclinical-research-supporting-product-candidate-for-rare-and-prevalent-heart-disease-indications-at-esc-heart-failure-2021/
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.